{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-000628","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2023-02-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.554889+00:00","generated_at":"2026-06-19T21:34:42.276906+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Two directors of CNBX Pharmaceuticals resign effective Jan 31, 2023","bullets":["Dr. Inbar Maymon Pomeranchik resigned as director; no disagreement with management.","Gil Feiler resigned as director; no disagreement with management.","Resignations occurred on January 31, 2023; no replacements announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-000628","json":"https://secwatch.observer/filing/0001683168-23-000628.json","markdown":"https://secwatch.observer/filing/0001683168-23-000628.md","text":"https://secwatch.observer/filing/0001683168-23-000628.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/0001683168-23-000628-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/cnbx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T21:34:42.276906+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1170d33846","claim":"Dr. Inbar Maymon Pomeranchik resigned as Director and Board Member at CNBX Pharmaceuticals Inc..","evidence_excerpt":"On January 31 st , 2023, Dr. Inbar Maymon Pomeranchik resigned from her position as a Director and Board Member.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/0001683168-23-000628-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Board Member"}],"fact_type":"executive_change"},{"claim_id":"6c093f2720","claim":"Gil Feiler resigned as Director and Board Member at CNBX Pharmaceuticals Inc..","evidence_excerpt":"Also on January 31 st , 2023, Gil Feiler also presented his resignation as a Director and Board Member.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316823000628/0001683168-23-000628-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Board Member"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}